December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting His presentations will describe Orion’s drug discovery platform, one of the fastest drug discovery solutions Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Oliver Hartley, Associate Professor at the University of Geneva and VP of Drug Discovery at Orion Biotechnology Therapeutics , Design Pharmaceuticals , Montana Molecular as well as the newest addition to our Ecosystem Orion Biotechnology for supporting Dr. In case you missed it, our friends at Orion Biotechnology published their first news in the Ecosystem